ITB Med
NY - New YorkBiotechnology
Focus: ITB Med is a New York-based biotechnology company focused on post-transplant treatment, with a pipeline spanning nephrology, immunology, metabolic diseases, dermatology, and rare diseases. The company is actively hiring across 6 open positions.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About ITB Med
AI assessmentNot HiringNo open roles listed right now. Follow ITB Med to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
13 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Siplizumab
Hidradenitis SuppurativaClinical Trials (1)
NCT06326476An Open-label, Time-lagged, Dose-escalation Study to Evalaute the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
Phase 1Help build intelligence for ITB Med
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.